Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2005
11/01/2005US6960572 Indolinones and uses thereof
10/2005
10/27/2005WO2005100505A1 New organic luminescent element
10/27/2005WO2005100347A1 Methods for minimizing thioamide impurities
10/27/2005WO2005100346A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005WO2005100344A1 Inhibitors of akt activity
10/27/2005WO2005100342A1 Pyridine inhibitors of erk2 and uses thereof
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2005100316A1 Crystalline polymorph of a bazedoxifene acetate
10/27/2005WO2005099709A2 Bicyclic heterocycles useful as serine protease inhibitors
10/27/2005WO2005099705A2 Preparation of imidazole derivatives and methods of use
10/27/2005WO2004048330A8 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/27/2005US20050239872 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
10/27/2005US20050239864 Novel tumor-selective chemotherapeutic agents
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239857 Novel imidazoles
10/27/2005US20050239855 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/27/2005US20050239841 New compounds
10/27/2005US20050239836 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050239811 Tri-substituted ureas as cytokine inhibitors
10/27/2005US20050239801 Novel compounds
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239777 Quinazoline derivatives and pharmaceutical compositions containing them
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239770 e.g. 3-{4-Cyclopentylamino-6-[(2,2-dimethyl-propyl)-methyl-amino]-pyrimidin-2-ylamino}-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005CA2563225A1 Process for preparing pyridazinone compounds
10/27/2005CA2562602A1 2-aminopyridine derivative
10/27/2005CA2561311A1 Inhibitors of akt activity
10/27/2005CA2561014A1 Thioamide derivatives as progesterone receptor modulators
10/27/2005CA2561010A1 Crystalline polymorph of bazedoxifene acetate
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1588707A1 Stable solid medicinal composition for oral administration
10/26/2005EP1587877A1 Beta-isoindigo coloring agent
10/26/2005EP1587803A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
10/26/2005EP1587585A1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/26/2005EP1587529A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1441683A4 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1129071B1 Phenyl-substituted cyclic enaminones
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688574A Indole-3-carboxamides as glucokinase(GK) activators
10/26/2005CN1688571A Substituted heterocyclylpyrimidines
10/26/2005CN1688555A Novel bicyclic inhibitors of hormone sensitive lipase
10/26/2005CN1688554A 1, 2, 4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/26/2005CN1688553A Chemical process
10/26/2005CN1688552A Pyrimidine derivatives and their use as CB2 modulators
10/26/2005CN1688550A 2, 5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1687059A Bi-triazole compound, preparation method and application thereof
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224622C Method for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/25/2005US6958402 3-(imidazolyl)-2-alkoxypropanoic acids
10/25/2005US6958356 Guanidine mimics factor Xa inhibitors
10/25/2005US6958353 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
10/25/2005US6958350 Chemical compounds
10/25/2005US6958348 Side effect reduction
10/25/2005US6958340 such as N-[3-methyl-5-(trifluoromethyl)phenyl]-4-(2-phenyl-1H-imidazol-1-yl)pyrimidin-2-amine; treating breast cancer; use in combination with estrogen receptor modulators such as tamoxifen and raloxifene
10/25/2005US6958339 Pyrazole derivative
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097778A1 Tetrahydrobenzazepines as histamine h3 receptor ligands
10/20/2005WO2005097776A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
10/20/2005WO2005097759A1 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/20/2005WO2005097758A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097740A1 Histamine h3 receptor agents, preparation and therapeutic uses
10/20/2005WO2005097137A2 Advanced quinazoline based protein kinase inhibitors
10/20/2005WO2005097136A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005WO2005097134A2 Quinazoline based protein kinase inhibitors
10/20/2005WO2005097112A2 Ion channel modulators
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005035525A3 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005WO2004076410A8 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005US20050234243 Novel diketopyrrolopyrrole pigments
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234236 Process for preparing pyridazinone compounds
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234098 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
10/20/2005US20050234083 Diamino-pyrimidines and their use as angiogenesis inhibitors
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234080 Mitotic kinesin inhibitors
10/20/2005US20050234072 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234064 2-(4-Methoxyphenyl)-amino-),3-(aminocarbonyl-)quinoxaline; janus(JAK) kinase inhibitors;spleen tyrosine kinase(SYK) inhibitors; glycogen synthase-3(GSK-3) kinase inhibitors; immunocompetance; antiinflammatory agents; antiallergens; autoimmune diseases; antiproliferative agents; respiratory disorders
10/20/2005US20050234059 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
10/20/2005US20050234055 Pyrazole derivative
10/20/2005US20050234049 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234042 Organic compounds
1 ... 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 ... 626